EndoCross, an Israeli firm, won the European CE Mark approval for its ENABLER-C Coronary Catheter System that’s used to cross chronic total occlusions. The ENABLER technology allows standard guidewires to be used to cross lesions by positioning a balloon before the occlusion that holds onto the vessel wall. A guidewire that can move through the balloon is repeatedly pushed forward, each time advancing a bit further. The balloon helps the guidewire stay straight and deliver the necessary pressure to the lesion needed to cross it.
More from the announcement followed by a video demonstrating how the ENABLER technology functions:
“EndoCross has developed a unique chronic occlusion crossing device that can facilitate penetration and crossing of complex occlusions with standard off-the-shelf wires. The device allows for effective and controlled luminal crossing.” said Dr. Maurice Buchbinder, M.D., Chief Medical Officer of EndoCross.
The ENABLER technology makes use of a propriety balloon design that allows for continuous and controlled luminal guidewire advancement through coronary chronic total occlusions (CTOs). “The addition of the Coronary Catheter System, together with our existing peripheral femoropopliteal and BTK solutions, provides physicians with the tools they need to make the crossing of CTOs a more straight forward, consistent, and successful procedure,” said Yaron Eshel, Chief Operating Officer of EndoCross.